Total Payments
$15,033
2024 Payments
$1,881
Companies
49
Transactions
565
Medicare Patients
17,269
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$11,839 (78.8%)
Travel$3,188 (21.2%)
Education$6.25 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,839 | 554 | 78.8% |
| Travel and Lodging | $3,188 | 10 | 21.2% |
| Education | $6.25 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,918 | 29 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,771 | 49 | $0 (2020) |
| Medtronic, Inc. | $1,406 | 50 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $855.46 | 52 | $0 (2024) |
| Abbott Laboratories | $778.78 | 38 | $0 (2024) |
| Esperion Therapeutics, Inc. | $722.23 | 31 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $623.24 | 40 | $0 (2024) |
| Amgen Inc. | $558.43 | 35 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $529.92 | 43 | $0 (2024) |
| AngioDynamics, Inc. | $499.46 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,881 | 58 | Medtronic, Inc. ($549.99) |
| 2023 | $4,183 | 85 | Boston Scientific Corporation ($2,647) |
| 2022 | $1,362 | 73 | Medtronic, Inc. ($317.28) |
| 2021 | $2,139 | 80 | AngioDynamics, Inc. ($484.62) |
| 2020 | $1,131 | 64 | Medtronic Vascular, Inc. ($410.94) |
| 2019 | $861.14 | 51 | Medtronic Vascular, Inc. ($171.35) |
| 2018 | $1,025 | 66 | Amgen Inc. ($178.88) |
| 2017 | $2,451 | 88 | Medtronic Vascular, Inc. ($1,103) |
All Payment Transactions
565 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Food and Beverage | In-kind items and services | $55.66 | General |
| Category: Stents | ||||||
| 12/12/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $35.22 | General |
| Category: CDS broad portfolio offering_CRM | ||||||
| 11/21/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $20.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $132.67 | General |
| Category: Coronary | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Vascular | ||||||
| 11/06/2024 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: WATCHMAN Pro_IC | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/04/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $24.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $25.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $72.37 | General |
| Category: Coronary | ||||||
| 10/14/2024 | Medtronic, Inc. | CLOSUREFAST (Device) | Food and Beverage | In-kind items and services | $34.29 | General |
| Category: EndoVenous Therapies | ||||||
| 10/02/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $42.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/25/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $22.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/25/2024 | Medtronic, Inc. | IN.PACT ADMIRAL (Device) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: Drug-Coated Balloons | ||||||
| 09/19/2024 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Stents | ||||||
| 09/18/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/17/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: CDS broad portfolio offering_CRM | ||||||
| 09/13/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $36.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/10/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/23/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $143.33 | General |
| Category: Coronary | ||||||
| 08/22/2024 | Medtronic, Inc. | ABRE (Device) | Food and Beverage | In-kind items and services | $120.44 | General |
| Category: Stents | ||||||
| 08/22/2024 | Medtronic, Inc. | COBALT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $108.28 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 45 | 5,656 | 7,593 | $1.5M | $406,665 |
| 2022 | 39 | 3,424 | 3,951 | $1.2M | $267,143 |
| 2021 | 40 | 3,943 | 4,841 | $1.1M | $310,727 |
| 2020 | 41 | 4,246 | 5,295 | $1.5M | $345,961 |
Total Patients
17,269
Total Services
21,680
Medicare Billing
$1.3M
Procedure Codes
177
All Medicare Procedures & Services
177 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 690 | 1,063 | $183,899 | $65,777 | 35.8% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 73 | 92 | $104,052 | $37,760 | 36.3% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 190 | 194 | $109,998 | $34,703 | 31.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 674 | 699 | $96,968 | $34,001 | 35.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 173 | 173 | $73,006 | $26,718 | 36.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 401 | 404 | $62,760 | $22,650 | 36.1% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 37 | 37 | $46,731 | $21,826 | 46.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 136 | 136 | $43,384 | $16,582 | 38.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 571 | 571 | $43,407 | $15,635 | 36.0% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 50 | 50 | $43,059 | $12,155 | 28.2% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 67 | 478 | $24,378 | $9,275 | 38.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 86 | 93 | $24,180 | $9,112 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 92 | $22,632 | $8,681 | 38.4% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 57 | 436 | $22,236 | $8,427 | 37.9% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 87 | 89 | $18,779 | $7,140 | 38.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 96 | 113 | $15,481 | $6,769 | 43.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 95 | 259 | $15,281 | $5,812 | 38.0% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 39 | 42 | $19,320 | $5,566 | 28.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 61 | 145 | $10,730 | $5,423 | 50.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 676 | 832 | $13,312 | $4,937 | 37.1% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 400 | 497 | $46,943 | $4,636 | 9.9% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 58 | 63 | $11,588 | $4,335 | 37.4% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 46 | 52 | $15,652 | $4,141 | 26.5% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 52 | 143 | $10,439 | $3,944 | 37.8% |
| 36246 | Insertion of tube into abdominal, pelvic, or leg artery, initial second order branch | Facility | 2023 | 22 | 23 | $37,743 | $3,895 | 10.3% |
About Dr. Christopher Higgins, MD
Dr. Christopher Higgins, MD is a Cardiovascular Disease healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2008. The National Provider Identifier (NPI) number assigned to this provider is 1417123274.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Higgins, MD has received a total of $15,033 in payments from pharmaceutical and medical device companies, with $1,881 received in 2024. These payments were reported across 565 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($11,839).
As a Medicare-enrolled provider, Higgins has provided services to 17,269 Medicare beneficiaries, totaling 21,680 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 177 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Internal Medicine, Internal Medicine
- Location Tulsa, OK
- Active Since 05/01/2008
- Last Updated 04/17/2014
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1417123274
Products in Payments
- Micra (Device) $992.11
- ELIQUIS (Drug) $633.37
- NEXLETOL (Drug) $597.89
- BRILINTA (Drug) $577.28
- Auryon Laser System 100-120 Vac (Device) $484.62
- Corlanor (Drug) $484.43
- ENTRESTO (Drug) $451.03
- FFRct (Device) $409.51
- LifeVest (Device) $385.05
- ABRE (Device) $366.06
- Impella (Device) $364.79
- VERQUVO (Drug) $271.68
- Vascepa (Drug) $252.43
- FARXIGA (Drug) $252.02
- HawkOne (Device) $215.25
- CardioMEMS HF System (Device) $200.47
- INSPIRIS RESILIA AORTIC VALVE (Device) $192.18
- Barostim Neo System (Device) $188.91
- ClosureFast (Device) $180.91
- Resolute (Device) $173.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Tulsa
Dr. Matthew Comstock, D.o, D.O
Cardiovascular Disease — Payments: $78,837
Cardiovascular Disease $78,837
Neil Agrawal, M.d, M.D
Cardiovascular Disease — Payments: $40,882
Cardiovascular Disease $40,882
Dr. David Wilkett, Do, DO
Cardiovascular Disease — Payments: $29,992
Cardiovascular Disease $29,992
Daniel Wildes, D.o, D.O
Cardiovascular Disease — Payments: $27,269
Cardiovascular Disease $27,269
Thomas Kalapura, Md, MD
Cardiovascular Disease — Payments: $18,323
Cardiovascular Disease $18,323
Dr. Jawad Trad, D.o, D.O
Cardiovascular Disease — Payments: $18,167
Cardiovascular Disease $18,167